This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Insulet Corp. (PODD) shed 2.73% to $296.19 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&amp;P 500 Index  falling 0.35% to 6,846.51 and Dow Jones Industrial Average  falling 0.45% to 47,739.32.
This was the stock's second consecutive day of losses.
Insulet Corp. closed 16.54% below its 52-week high of $354.88, which the company achieved on November 20th.
The stock underperformed when compared to some of its competitors Monday, as Eli Lilly &amp; Co. (LLY) fell 1.26% to $997.59, DexCom Inc. (DXCM) rose 0.20% to $65.62, and Johnson &amp; Johnson (JNJ) fell 0.15% to $201.62.
Trading volume (623,164) remained 27,939 below its 50-day average volume of 651,103.
Data source: Dow Jones Market Data, FactSet. Data compiled December 8, 2025.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-08-25 1706ET

DXCM

PODD

<p>Insulet Corp. (PODD) shares fell 2.73% to $296.19 on Monday, underperforming compared to competitors. The stock is 16.54% below its 52-week high of $354.88. Eli Lilly & Co. (LLY) fell 1.26%, DexCom Inc. (DXCM) rose 0.20%, and Johnson & Johnson (JNJ) fell 0.15%. Trading volume was below the 50-day average.</p>

Insulet Corp. Stock Underperforms Monday When Compared To Competitors